Development and translation of advanced motion correction technologies for cardiac pet/CT
Active Project Grant Awarded Last action
- Award ID
- R01HL169868
- Recipient
-
Yale Univ UEI FL6GV84CKN57
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,933,747
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date 64% complete
- Place of performance
- Connecticut, USA
Award details come from USAspending.gov.
Description
- Abstract
- Motion effects (including respiratory motion, body motion, cardiac motion) and associated mismatched attenuation correction substantially degrade the cardiac pet image quality and quantitative accuracy. Although a number of motion correction methods have been implemented on clinical scanners, they 1) are largely respiratory motion corrections requiring external motion tracking hardware; and 2) does not take into account motion-induced pet-CT mismatch in attenuation correction. The correction of motion for 82RB cardiac dynamic pet imaging is particularly challenging, as the rapid tracer kinetics of 82RB leads to substantial tracer distribution change in the dynamic frame images over time. 82RB's ultra-short half-life of only 75 seconds also poses additional significant challenges of image noise. In this R01, we propose to develop a series of motion correction methods with aligned pet-CT for both static and dynamic cardiac applications. All the new developments proposed here are data-driven based approaches, meaning no external motion tracking hardware is required. We will focus on cardiac pet data with 82RB as the tracer, while most of the developments can be directly applied to other tracers. The proposed motion correction technology developments and translations will have a significant impact on both currently used clinical protocols and emerging new applications, such as evaluation of endocardial/epicardial (EN/EP) flow ratios. Specifically, in aim 1, we will develop and optimize respiratory and bulk body motion correction methods. In aim 2, we will develop and optimize data-driven methods to correct cardiac (intra-beat) motion. In aim 3, we will develop methods to correct pet/CT MIS-alignment due to motion. All the developed technologies will be evaluated and validated using human and large animal data. In aim 4, the industry partner of this grant will translate the developed motion correction methods to end-users.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $587,428 | |
| Amendment | $68,604 | |
| Amendment | $617,443 | |
| Amendment | $617,443 | |
| Amendment | $680,943 | |
| Amendment | $680,943 | |
| Original award | $680,943 |
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| Siemens Medical Solutions Usa, Inc. | $56,779 | |
| Siemens Medical Solutions Usa, Inc. | $183,930 | |
| The Methodist Hospital Research Institute | $375,997 |
Quick answers
Who received award R01HL169868?
R01HL169868 was awarded to Yale Univ by National Heart Lung and Blood Institute (National Institutes of Health) on April 17, 2024.
How much is award R01HL169868 worth?
$3,933,747 has been obligated on R01HL169868.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award